Insulin-like Growth Factor-Binding Protein-1 (IGFBP-1) as a Biomarker of Cardiovascular Disease
Moira S Lewitt, Gary W Boyd, Pietro Scicchitano · 2024
Read Insulin-like Growth Factor-Binding Protein-1 (IGFBP-1) as a Biomarker of Cardiovascular Disease by Moira S Lewitt, Gary W Boyd, Pietro Scicchitano (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11592324.txt.
Description
Moira Lewitt and co-authors review a blood protein as a possible warning sign for heart disease in a 2024 article. The protein, called IGFBP-1, helps control growth factors that steer metabolism and growth, and it also acts on its own. The liver makes it, insulin holds it down, and inflammation pushes it up.
The review weighs a confusing pattern. Low levels of the protein go with a risky profile of weight, sugar, and blood fats. Yet high levels predict worse outcomes once heart disease is present. Levels also shift with sex and age, which muddy simple readings. The authors suggest richer tests, such as measuring the protein alongside insulin output after a sugar drink, and panels that add inflammation markers, to sort out what a reading really means.
Catalog record
| CREATOR | Moira S Lewitt, Gary W Boyd, Pietro Scicchitano |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |